VC Funding for Bay State Biotechs Dropped 36 Percent
A major source of funding for Massachusetts life science companies dropped sharply in 2022, but still exceeds pre-pandemic investment levels.
Developers Look Beyond Labs for Value Investments
Dozens of commercial developers have shifted their focus to lab projects amid the boom, others see overlooked opportunities in the industrial market’s R&D and flex space.
No Lab Rent Relief Seen Before 2023
A projected 18 million square feet of lab space is scheduled for completion in Greater Boston in 2023, potentially tempering the skyrocketing rent increases being driven by the life science industry’s space demand.
Cross-Border Investors Bullish on Boston
Institutional investors rank Boston as the second-most desirable U.S. market for investment in 2021 and the only non-Sunbelt metro in the top four.
Capital Markets Look for Clarity
There remains plenty of capital for real estate ventures and funds are being raised, but investors are selective on where that capital is being placed.
Vote Now for B&T’s Best of 2024!
